SCOPUS 정보 검색 플랫폼

Clinical Diabetes

Volumn 28, Issue 1, 2010, Pages 30-33

Case study: Experience in insulin pump therapy during the neonatal period

(3) Begum Hasan, Jahanara a Bruce, Aisha A K b Koster, JoAnn c

a VIRGINIA TECH CARILION SCHOOL OF MEDICINE (United States)

b QUEEN S UNIVERSITY (Canada)

c HOTEL DIEU HOSPITAL (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN; INSULIN ASPART; INSULIN ZINC SUSPENSION; ISOPHANE INSULIN;

ARTICLE; CASE REPORT; CLINICAL EXAMINATION; DIABETES MELLITUS; DRUG DOSE TITRATION; DRUG SUBSTITUTION; FEMALE; HUMAN; INFANT; INSULIN PUMP; INTENSIVE CARE UNIT; LETHARGY; NEWBORN; NEWBORN DIABETES MELLITUS; NEWBORN PERIOD; OLIGOHYDRAMNIOS; SMALL FOR DATE INFANT;

EID: 75449110771 PISSN: 08918929 EISSN: None Source Type: Journal
DOI: 10.2337/diaclin.28.1.30 Document Type: Article

Times cited : (1)

References (6)

1
- 33644818105
- Neonatal diabetes mellitus: Insulin pump as an alternative management strategy
- Bharucha T, Brown J, McDonnell C, Gebert R, McDougall P, Cameron F, Werther G, Zacharin M: Neonatal diabetes mellitus: insulin pump as an alternative management strategy. J Pediatr Child Health 41:522-526, 2005
- (2005) J Pediatr Child Health , vol.41 , pp. 522-526
- Bharucha, T.¹ Brown, J.² McDonnell, C.³ Gebert, R.⁴ McDougall, P.⁵ Cameron, F.⁶ Werther, G.⁷ Zacharin, M.⁸

2
- 23944448616
- Case study: Challenges of insulin pump therapy in a toddler and adolescent with type 1 diabetes
- Doyle EA, Steffen AT, Tamborlane WV: Case study: challenges of insulin pump therapy in a toddler and adolescent with type 1 diabetes. Diabetes Educ 31:584-590, 2005
- (2005) Diabetes Educ , vol.31 , pp. 584-590
- Doyle, E.A.¹ Steffen, A.T.² Tamborlane, W.V.³

3
- 14644430260
- Persistence of benefits of continuous subcutaneous insulin infusion in very young children with type 1 diabetes: A follow-up report
- Weinzimer SA, Ahern JH, Doyle EA, Iincent MR, Dziura J, Steffen AT, Tamborlane WV: Persistence of benefits of continuous subcutaneous insulin infusion in very young children with type 1 diabetes: a follow-up report. Pediatrics 114:1601-1605, 2004
- (2004) Pediatrics , vol.114 , pp. 1601-1605
- Weinzimer, S.A.¹ Ahern, J.H.² Doyle, E.A.³ Iincent, M.R.⁴ Dziura, J.⁵ Steffen, A.T.⁶ Tamborlane, W.V.⁷

4
- 33745298028
- Feasibility and safety of insulin pump therapy in children aged 2 to 7 years with type 1 diabetes: A retrospective study
- Berhe T, Postellon D, Wilson B, Stone R: Feasibility and safety of insulin pump therapy in children aged 2 to 7 years with type 1 diabetes: a retrospective study. Pediatrics 117: 2132-2137, 2006
- (2006) Pediatrics , vol.117 , pp. 2132-2137
- Berhe, T.¹ Postellon, D.² Wilson, B.³ Stone, R.⁴

5
- 4644260056
- Permanent neonatal diabetes due to mutaions in KCNJ11 encoding Kir6.2: Patient characteristics and initial response to sulfonylurea therapy
- Sagen JV, Raeder H, Hathout E, Shehadeh N, Gudmundsson K, Baevre H, Abuelo D, Phornphutkul C, Molnes J, Bell GI, Gloyn AL, Hattersley AT, Molven A, Søvik O, Njølstad PR: Permanent neonatal diabetes due to mutaions in KCNJ11 encoding Kir6.2: patient characteristics and initial response to sulfonylurea therapy. Diabetes 53: 2713-2718, 2004
- (2004) Diabetes , vol.53 , pp. 2713-2718
- Sagen, J.V.¹ Raeder, H.² Hathout, E.³ Shehadeh, N.⁴ Gudmundsson, K.⁵ Baevre, H.⁶ Abuelo, D.⁷ Phornphutkul, C.⁸ Molnes, J.⁹ Bell, G.I.¹⁰ Gloyn, A.L.¹¹ Hattersley, A.T.¹² Molven, A.¹³ Søvik, O.¹⁴ Njølstad, P.R.¹⁵

6
- 8744262895
- Glibenclamide treatment in permanent neonatal diabetes mellitus due to an activating mutation in Kir6.2
- Zung A, Glaser B, Nimri R, Zadik Z: Glibenclamide treatment in permanent neonatal diabetes mellitus due to an activating mutation in Kir6.2. J Clin Endocrinol Metab 89:5504-5507, 2004
- (2004) J Clin Endocrinol Metab , vol.89 , pp. 5504-5507
- Zung, A.¹ Glaser, B.² Nimri, R.³ Zadik, Z.⁴

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.